Doc DNTA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
17-07
micro format · 14 days before the deadline
2025
31-12
Financial
Liquidity more than triplescurrent ratio 3.30
The current ratio rises from 0.90 to 3.30. Short-term debt falls from €27,341 to €4,962.
31-07
micro format · on the deadline day
2024
24-05
Gazette deed
IncorporationStarting capital €3,000 · Appointment: DANG Ngoc Tran Amélie (director) · Founder9 points ▸
Gazette deed
Incorporation
Starting capital €3,000 · Appointment: DANG Ngoc Tran Amélie (director) · Founder9 points ▸
- Incorporation, “Doc DNTA” (deed in Dutch)
- Founder, DANG Ngoc Tran Amélie (comparant)
- Founding capital, €3,000
- Other provision, “authentieke akte, vaststelling statuten bij oprichtingsakte” (deed in Dutch)
- Capital
- Board rule, “beperkt, duur medische activiteiten”, 1 (deed in Dutch)
- Director appointment, DANG Ngoc Tran Amélie (director)
- Other provision, “dag verkrijging rechtspersoonlijkheid, begin werkzaamheden” (deed in Dutch)
- Pre-incorporation commitments, “takeover, alle handelingen gedaan in haar naam door comparanten” (deed in Dutch)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
On 22 May 2024, Doc DNTA was incorporated as a private limited company by one natural person, with a starting capital of €3,000.12 DANG Ngoc Tran Amélie is director of the company, appointed in the act of 24-05-2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3